In vitro, overexpression of TIM3 by CL4 CTL and treatment with an A2AR agonist inhibited killing of tumor cells in tumor spheroids and the A2AR agonist also reduced spheroid infiltration by CTL. Here, HAVCR2 is linked to neoplasm.